Phase II Trial GA101 Inbrutinib B CLL
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
HD21 for Advanced Stages
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Allo HSCT Using RIC for Hematological Diseases
- Status
- COMPLETED
- Phase
- PHASE2
Modified MRCUKALLⅫ/ECOGE2993 Regimen for ALL
- Status
- UNKNOWN
- Phase
- PHASE2
T Cells Expressing a Fully-human AntiCD19 Chimeric Antigen Receptor for Treating B-cell Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Stage I-II HER2/Neu Positive Breast Cancer After Surgery
- Status
- COMPLETED
- Phase
- PHASE2
TCR-α/β and CD19 Depleted Stem Cell Grafts From Haplo Donors for HSCT in Relapsed Lymphoma
- Status
- COMPLETED
- Phase
- NA
Combining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic Melanoma
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Humanized Anti-GD2 Antibody Hu3F8 and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE1
TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Study With CY, Pembrolizumab, GVAX Pancreas Vaccine, and SBRT in Patients With Locally Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Comparison of Low Dose Versus High Dose Cyclophosphamide as Induction Therapy in the Treatment of Lupus Nephritis
- Status
- COMPLETED
- Phase
- PHASE4
SPI-2012 vs Pegfilgrastim in the Management of Neutropenia in Participants With Breast Cancer With Docetaxel and Cyclophosphamide (ADVANCE)
- Status
- COMPLETED
- Phase
- PHASE3
TA(E)C-GP Versus A(E)C-T for the High Risk TNBC Patients and Validation of the mRNA-lncRNA Signature
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor
- Status
- RECRUITING
- Phase
- PHASE3
A Pilot Preoperative Trial of Ganetespib With Paclitaxel for Triple-Negative Breast Cancer
- Status
- WITHDRAWN
- Phase
- NA
Smart Start: A Phase II Study of Rituximab, Lenalidomide, and Ibrutinib
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Metronomic CP and JX-594 in Patients With Advanced Breast Cancer and Advanced Soft-tissue Sarcoma (METROmaJX)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Ibrutinib, Fludarabine Phosphate, Cyclophosphamide, and Obinutuzumab in Treating Patients With Chronic Lymphocytic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2